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DRUG:  INDOMETHACIN 
PRESENTATION:  Vial prepared by KEMH CIVAS: 1mg/5mL  (200microgram/mL) 
Oral Suspension: 250 microgram/mL  
ACTION & 
INDICATION: 
Prostaglandin synthetase inhibitor 
Closure of haemodynamically significant patent ductus arteriosus 
Prevention of intraventricular haemorrhage 
DOSE: 
 
IV: 
Initial dose: 200microgram/kg/dose  
Subsequent doses: 100-200microgram/kg/dose every 24 hours for 2 
doses. 
A further 2 doses may be given if required ( max. 5 doses) 
Oral : 
Initial and subsequent dose: 200microgram/kg/dose every 24 hours for  
3 - 5 doses.  
(Infant must be on at least 100mL/kg/day of oral feeds before starting 
oral administration) 
PREPARATION:  IV: No further dilution required (200micrograms/mL )  
Oral Suspension prepared in Pharmacy 
STORAGE:  IV: SCN3 Fridge 
Refer to outer packaging for updated expiry date (28 days post  
defrosting) 
Vials are kept frozen in Pharmacy prior to supply to NCCU 
ADMINISTRATION: 
 
Intravenous: Infuse over 20-30 minutes. Flush line over at least 30 
minutes. 
Oral: Given with or immediately after feeds. 
ADVERSE 
EFFECTS: 
 
Hyponatraemia, hyperkalaemia, oedema, GI bleeding, abdominal 
distension, transient ileus, NEC, decreased platelet aggregation 
Nephrotoxicity - use with caution with other renally excreted drugs. 
COMMENTS:  Monitor urea and electrolytes.  
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